From: _____________________________________________________________ &gt;
To: _____________________________________________________________ &gt;

Subject: Fwd: 6031_03C.PATIENT CARE
Date: Tue, 13 Aug 2019 14:03:45 +0000
Importance: Normal
Attachments: TEXT.htm; 6031_03C.PATIENT_CARE.docx

Good Morning,

We need to find time to review the attached Supplement to ensure it is up to date. I would like to add the Naloxone in it instead of creating a new Supplement just for Naloxone. This is what the other institutions have done. Your thoughts? Thanks.

Associate Warden
MCC New York
New York, New York 10007

&gt;&gt;&gt; 8/12/2019 10:54 AM &gt;&gt;&gt;
Please see the attached.

EFTA00036891